Andrew Satz, MSc

Miami, Florida, United States
Andrew Satz is the founder and CEO of EVQLV, a technology company accelerating antibody design and development. A data scientist by training, Andrew is a passionate technologist and innovator with nearly two decades in applied artificial intelligence. He has founded or led technology companies across multiple industries, including biotech, where he helped bring 3 drugs from discovery to IND. He co-developed EVQLV's antibody discovery engine, which uses a wide range of machine learning and software engineering techniques to scale and speed the design and screening of therapeutic antibodies.
Speaking In
1:00 PM - 2:00 PM (PDT)
Monday, June 13
Learn how different organizations are approaching using AI/ML, their thoughts on the challenges and…